Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 87 clinical trials
featured
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-angle Glaucoma or Ocular Hypertension

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle

bimatoprost
intraocular pressure
pigmentary glaucoma
pseudoexfoliation glaucoma
hypertension
  • 78 views
  • 23 Nov, 2020
  • 1 location
featured
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

To compare the safety and efficacy of Perrigo's product to an FDA approved product in the treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes.  

ocular hypotensive
brimonidine tartrate ophthalmic solution
glaucoma
hypotensive
corrected visual acuity
  • 109 views
  • 23 Nov, 2020
  • 1 location
featured
DE-117 Spectrum 5 Study

Santen will evaluate the intraocular pressure (IOP) lowering effect and efficacy of DE-117 ophthalmic solution 0.002% in latanoprost/non-responder subjects diagnosed with POAG or OHT &nbsp

glaucoma
intraocular pressure
brimonidine tartrate ophthalmic solution
ophthalmic solution
latanoprost
  • 69 views
  • 23 Nov, 2020
  • 1 location
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma

trabeculectomy
pigmentary glaucoma
laser trabeculoplasty
  • 194 views
  • 07 Nov, 2020
  • 1 location
CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma

This is a randomized, parallel arm, multicenter, double-blind trial. Patients with POAG will be randomized 1:1 ratio to receive: Prostaglandin analogue (PGA) monotherapy

brimonidine tartrate ophthalmic solution
ophthalmic solution
primary open angle glaucoma
prostaglandin
  • 18 views
  • 08 Nov, 2020
  • 1 location
InnFocus MicroShunt Versus Trabeculectomy Study

Assess the safety and effectiveness of the InnFocus MicroShunt when used to lower intraocular pressure (IOP) in subjects with primary open angle glaucoma where the IOP is not controlled when using

glaucoma surgery
intraocular pressure
trabeculectomy
pigmentary glaucoma
primary open angle glaucoma
  • 481 views
  • 17 Jan, 2018
  • 26 locations
Effect of Metformin on Visual Function in Patients With Glaucoma

The purpose of this study is to determine whether Metformin could prevent the progression of glaucoma in a safe and effective manner.

migraine
headache
filtration surgery
hypertension
metformin
  • 6 views
  • 16 Dec, 2019
  • 1 location
Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans

), primary Baerveldt tube with MMC and Baerveldt tube without MMC - in black African/African Caribbean patients with Primary Open Angle Glaucoma (POAG) living in London. The UK Office of National

primary open angle glaucoma
glaucoma surgery
trabeculectomy
mitomycin
pigmentary glaucoma
  • 5 views
  • 08 Nov, 2020
  • 1 location
iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma

  • 31 views
  • 08 Nov, 2020
  • 1 location
A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

The purposes of this study are to determine the optimal concentration of DE-117 ophthalmic solution compared to the placebo ophthalmic solution and to determine if intraocular pressure reduction after 4 weeks of treatment with DE-117 ophthalmic solution is non-inferior to latanoprost ophthalmic solution 0.005%.

pigmentary glaucoma
latanoprost ophthalmic solution
hypertension
latanoprost
glaucoma
  • 0 views
  • 08 Nov, 2020
  • 1 location